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Abstract
Integrin  is overexpressed on neoendothelial cells and frequently on tumor cells. We have developed a peptide-like scaffoldαvβ3
(RAFT), which holds 4 -RGDfK-  (cRGD) motifs and proved that this molecule (called RAFT-RGD) targets integrin  cyclo[ ] αvβ3 in
 and . Using Fluorescence Correlation Spectroscopy, we measured the constant of affinity (K ) of the RAFT-RGD forvitro in vivo D
purified integrins. K  values rose from 3.87 nM for RAFT-RGD to 41.70 nM for -RGDfK- . In addition RAFT-RGD inhibited D cyclo[ ] α
 lateral mobility in the cell membrane, due to the formation of integrin-clusters as demonstrated by Fluorescence Recovery aftervβ3
Photobleaching. This was confirmed by electronic microscopy data, which established the formation of molecular complexes
containing 2 integrins in the presence of RAFT-RGD but not cRGD or RAFT-RAD. Using an Enzyme-Linked ImmunoSorbent Assay,
we proved that 1 M RAFT-RGD increased by 79   internalization via clathrin-coated vesicles. Conversely, cRGD wasμ % αvβ3
internalized without modifying  internalization. Although RGD has been known for more than 20 years, this is the first study toαvβ3
formerly establish the relationships between multimeric presentation, increased affinity and subsequent integrin mediated
co-internalization. These results strongly support the rationale for using multimeric RGD peptides as targeting vectors for imaging,
diagnosis or therapy of cancers.
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Introduction
Targeting tumor angiogenesis for specific drug transfer into tumor masses and metastasis has been identified as a promising approach
for three main reasons: i) angiogenesis is a common and genetically stable characteristic of most solid tumors, ii) it is readily accessible
from the blood stream and iii) it can be targeted by specific RGD-containing peptides binding integrin . This integrin is indeed poorlyαvβ3
expressed on quiescent vessels and is selectively overexpressed on activated endothelial cells of growing vessels. In addition, integrin αvβ3
is also frequently overexpressed on tumor cells, as observed in lung cancers , , melanomas , brain tumors  or breast cancers .[1 2] [3] [4] [5]
Integrins are membrane-spanning heterodimers of  and  subunits, both of which comprise a short cytoplasmic tail, a singleα β
transmembrane helix and a large extracellular domain . Most integrins are expressed in a default low-affinity ligand-binding state but[6]
their conformation and affinity can vary in response to cellular and microenvironment stimulations , . This will also affect their lateral[7 8]
assembly and clustering on the surface of the cell . Several groups have developed multimeric RGD-presenting molecules, with the aim[9]
not only to increase integrin affinity and clustering but also to induce an active integrin-mediated internalization .[10–12]
We have developed a Regioselectively Addressable Functionalized Template (RAFT) cyclo-decapeptide scaffold, able to present 4
cyclic RGD pentapeptide motifs. We have shown using nuclear or optical imaging methods, that RAFT-RGD allows an improved and αvβ3
-specific targeting and drug delivery  as well as  imaging of tumors as compared to the monomeric cyclic RGD (cRGD) .[13] in vivo [14–17]
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Surprisingly, while the interaction between RGD-ligands and integrins has been known for a long time ,  and RGD-containing[18 19]
molecules been widely used to deliver various kinds of cargos including nanoparticles (liposomes or polymers), cytotoxic peptides, low
molecular weight drugs and contrast-enhancing agents (fluorochromes, radiotracers) , , very little is known about the[12 20–22]
internalization mechanism of RGD peptides binding to integrin .αvβ3
Two studies have described how an antibody directed against integrin  (mAb 17E6) and monomeric or multimeric RGD peptidesαvβ3
are internalized. Both concluded that the internalization of monomeric RGD ligands is independent of its  receptor and occurs via aαvβ3
fluid-phase endocytic pathway. In contrast, multimeric RGD molecules are co-internalized with their receptor , , evidence in favor of[23 24]
integrin aggregation and clustering.
The integrin endo/exocytic cycle  suggests that there are, at least, three types of pathways associated with integrin[25–27]
internalization: 1/clathrin-mediated endocytosis was described for  integrins ; 2/caveolae-mediated endocytosis for  integrins αvβ5 [28] α2 [29]
and 3/clathrin-caveolae-independent endocytosis. To our knowledge, endocytosis of  integrins was described to occur throughαvβ3
clathrin-dependent endocytosis  or uncoated vesicles . Clathrin-dependent endocytosis has also been described for viruses such as[30] [31]
adenoviruses that enter the cells after binding to the  integrin secondary receptor .αvβ3 [32]
Here, we studied the biological properties of the tetrameric RAFT-RGD peptide (coupled or not to fluorescent probes) as compared to
those of its monomeric counterpart cRGD so as to better understand and improve the potential of RGD-based vectors to specifically
deliver therapeutic drugs directly inside the target cells. We measured their affinity (K ) for the purified integrin  in solution.D αvβ3
Results
Affinities of RAFT-RGD versus cRGD for the purified, soluble integrin αvβ3
Fluorescence correlation spectroscopy (FCS) is commonly used to characterize the dynamics of fluorescent molecules in solution. This
technique allows users to measure fluorescence intensity fluctuations due to diffusion phenomenon, chemical reactions, aggregation  We…
first established the diffusion properties of each fluorescently labeled RGD-containing molecules in solution and then measured the
variation of this parameter in the presence of a large excess of purified integrins. This provided quantitative information allowing the
determination of a constant of association (K ).D
FCS analysis indicated that the tetrameric RAFT-RGD-Cy5 had a 10-fold higher affinity for its soluble receptor integrin  in HBSSαvβ3
(containing Ca /Mg ) than the monomeric cRGD-Cy5 ( ). Its dissociation constant (K ), obtained by curve fitting with a2+ 2+ Fig. 1b D
two-component model, was 3.87 nM while the K  of cRGD-Cy5 reached 41.70 nM. The non-specific RAFT-RAD-Cy5 did not interactD
with integrin : the data fitted neither a two- nor even a three-component model but only fitted a one-component model, correspondingαvβ3
to free RAFT-RAD-Cy5. The K  of RAFT-RGD-Cy5 was also determined for a non-specific receptor integrin : in this case, theD α3β1
measured K  was 1147 nM,  300 fold higher than the one obtained with .D i.e. αvβ3
RAFT-RGD slows down integrin  mobility in the cell membraneαvβ3
We measured the mobility of integrin  in the membrane of adherent HEK293( ) cells in the presence of the different peptides byαvβ3 β3
FRAP analysis using a confocal microscope. These cells expressing natural amount of the human  chain were stably transfected with aαv
plasmid encoding for the human  chain. We focused the laser beam on the apical membrane for two reasons: 1/integrins from this regionβ3
are mobile because they are not engaged in cell-matrix adhesions and 2/this area is less affected by cell shrinkage usually observed in the
presence of RGD peptides. Adherent cells were co-incubated for 8 min with the different peptides and the R-PhycoErythrin-labeled
LM609 antibody. After the RPE photobleaching in a defined area (ROI), the time for fluorescence recovery due to the lateral movement of
RPE-labeled integrins on the membrane was measured ( ). Importantly, we initially verified that LM609 s binding was not affected byFig. 2 ’
the presence of the peptides (data not shown). Also, no significant cellular movement or changes in membrane curvature occurred during
fluorescence sampling. Results presented in  indicate that the presence of RAFT-RGD-FITC peptide dramatically slowed down theFig. 2
recovery of the integrin signal into the bleached area as compared to untreated cells. In contrast, no decrease in the time of recovery was
observed either by using the negative control peptide RAFT-RAD-FITC or with the monovalent cRGD-FITC. The apparent diffusion time,
calculated from the fluorescence recovery curves obtained on twenty individual cells (three separated experiments), increased from 46  14±
seconds (RAFT-RAD-FITC, cRGD-FITC and PBS) to 144  22 seconds (RAFT-RGD-FITC). No concomitant change in peptide±
distribution was induced during FRAP experiments as monitored in the FITC detection channel. The fluorescence recovery being directly
correlated to the mobility of the receptor, these results suggested that the presence of the tetrameric RAFT-RGD-FITC slowed down αvβ3
integrin diffusion within the cell membrane by linking several integrins together,  by clustering integrins.i.e.
RAFT-RGD can bind two  integrins simultaneouslyαvβ3
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In order to confirm the data obtained by FRAP, we aimed at visualizing the possible formation of integrin clusters induced by
RAFT-RGD. We used negative staining electron microscopy to observe  integrin and /RGD-peptides mixed in 1 mM Mg /Caαvβ3 αvβ3 2+ 2+
as illustrated in . Peptides were used in excess as compared to the integrin concentration. These conditions are not supposed toFig. 3
maximize the number of dimers. Integrins alone or mixed with cRGD or RAFT-RAD displayed compact particles representing single
heterodimers of   RGD as expected. Indeed, the monomeric cRGD does not have the possibility to interact with several integrins atαvβ3 ±
the same time, while the RAFT-RAD is not able to recognize them at all. Conversely /RAFT-RGD micrographs were frequentlyαvβ3
showing larger particles corresponding to complexes of two  integrins probably linked by the multimeric RAFT-RGD. Visually, weαvβ3
estimated that about 10  of /RAFT-RGD were forming integrin dimers. But, this percentage was most probably underestimated% αvβ3
because we counted only the aggregates laying on the grid in a proper angle of examination and providing particles with this typical
dimer-shape. For example, clusters viewed down the long axis would appear more compact  and were not included (the staining agent[33]
outlines only those parts of the objects that are in contact with the carbon film). Nevertheless, electron microscopy is a qualitative
technique and not a quantitative technique: dimers of integrins may bind with less affinity to the carbon than monomeric integrins, thus
leading to underestimate the number of dimers.
RAFT-RGD-mediated integrin  internalizationαvβ3
RAFT-RGD-Cy5 and cRGD-Cy5 internalizations were observed by confocal microscopy on live HEK293( ) cells ( ).β3 Fig. 4
RAFT-RGD-Cy5 was rapidly internalized in small vesicles after 10 min ( ) but was also found in the cytoplasm and at cell-cellFig. 4a
contacts. Monomeric cRGD-Cy5 internalization is less extensive than that of RAFT-RGD-Cy5 and the laser intensity had to be increased
three times in order to obtain comparable signal intensities ( ).Fig. 4E
We then developed a special ELISA assay to demonstrate that RGD-peptides were inducing integrin  internalization. Briefly,αvβ3
integrins exposed on the surface of HEK293( ) cells were biotinylated and the cells were incubated in the presence of 0 to 1 Mβ3 μ
RAFT-RGD or 0 to 4 M cRGD for 10 min in order to keep the number of RGD motifs constant. The cells were then lysed, fractionatedμ
and the concentration of biotinylated- -integrins present into each fraction measured using ELISA. The absence of peptide (controlαvβ3
condition) established the normal endocytosis of integrin ; we found that 12  1  of the labeled integrins are internalized naturally  inαvβ3 ± % “ ”
10 min ( ). In the presence of RAFT-RGD, internalization increased in a dose-dependent manner and reached 21  2  at 1 M,Table 1 ± % μ
corresponding to an increase of 79   control. In contrast, increasing doses of cRGD (from 0.1 to 4 M) did not affect integrin% vs. μ
internalization at all, which remained similar to that of the control ( . 12  1  at 1 M). Altogether this indicated that RAFT-RGDi.e ± % μ
internalization was correlated with integrin  endocytosis, while the monomeric cRGD did not affect  natural endocytosis.αvβ3 αvβ3
RAFT-RGD internalization occurs via clathrin-mediated endocytosis
RAFT-RGD-Cy5 and cRGD-Cy5 internalization pathways were analyzed using confocal microscopy in the presence of specific
inhibitors ( ). In the presence of the clathrin-inhibitor amantadine at 1 mM ( ), RAFT-RGD-Cy5 internalization was extensivelyFig. 4 Fig. 4b
inhibited. The fluorescence was found at the cell surface mainly and especially at the cell-cell contacts. In contrast, amantadine did not
affect cRGD-Cy5 internalization (compare ). One M of nystatin, an inhibitor of caveolae-dependent internalization had noFig. 4e and 4f μ
effect on either peptide ( ). In the presence of 1 mM amiloride, internalization of the peptides remained unchanged (Fig. 4c and 4g Fig. 4d
) although, we proved by using 70 kDa-dextran-FITC, that macropinocytose was correctly inhibited in these cells (data not shown).and 4h
These results were confirmed by the ELISA measurements of the integrin  amount internalized after binding to RAFT-RGD in theαvβ3
presence of amantadine, nystatin or amiloride ( ). In the presence of amantadine, 1 M of RAFT-RGD was not able any more toTable 1 μ
induce integrin internalization and the  of internalized integrins was exactly similar to the control values (12  2 ). In contrast, nystatin% ± %
or amiloride did not prevent RAFT-RGD-induced integrin  internalization. These data suggested that RAFT-RGD was internalizedαvβ3
with integrin  via the clathrin-dependent pathway. Furthermore, peptides internalization was quantified from confocal microscopyαvβ3
analysis. The related peptide internalization indexes are reported  (mean of Cy5-intensity/pixels). Those indexes confirmed thatFigure 4
RAFT-RGD internalization occurred in a clathrin-dependent pathway, but also that RAFT-RGD gets into the cells more efficiently than
cRGD.
Discussion
Drug vectorization mediated by specific tumor-targeting molecules could allow specific delivery of cytotoxic agents to tumors
therefore limiting their systemic toxicity. Based on this concept, RGD-containing peptides have been largely used for the targeting of αvβ3
-integrin expressing tumors and/or of their microvasculature. Our group contributed to the development of a synthetic multimeric
RGD-based vector, called RAFT-RGD. This peptide proved to be particularly efficient for the delivery of drugs, imaging agents or both [
, ,  . However, although RGD-integrin interaction has been discovered a long time ago , , the mechanism of14–16 17 34 ] [18 19]
internalization of monomeric or multimeric RGD peptides is a poorly documented process. In this study, we focused our attention to the
study of the mechanism by which the well-known cRGD, similar to the original cyclic peptide developed by Kessler et al. ,  and its[35 36]
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RAFT-supported tetrameric version RAFT-RGD are internalized, with a particular emphasis on the internalization pathways involved after
recognition and binding to the  receptor.αvβ3
Multimeric RGD-peptides are expected to present an increased affinity for the  integrin as compared to their monomericαvβ3
counterpart. This has been demonstrated when comparing cyclic versus linear RGD-based peptides , . We confirmed this[37 38]
characteristic for the RAFT-RGD using an FCS assay. RAFT-RGD-Cy5 bound specifically to integrin  with a 10 fold higher affinityαvβ3
than cRGD ( ). Surprisingly, although integrins are known to present at least two affinity states, we measured only one K  value forFig. 1b D
both RAFT-RGD-Cy5 and cRGD-Cy5. In addition, the K  value measured for cRGD was about 25 times higher than previously reportedD
values , . This suggested that, in our FCS assay, integrins were exclusively in their activated form as a result of the combined[38 39]
presence of octyl- -D-glucopyranoside (unpublished observations), Mg  ions ,  and of cRGD peptides ,  in the media, each ofβ 2+ [40 41] [9 42]
these factors being known to switch integrins in their high affinity state. In addition, it must be noticed that previous measurements of the
K  described in the literature were based on solid-phase receptor binding assays. In our case, integrins were in solution and this certainlyD
modified their constant of affinity.
Using FRAP, we also demonstrated that the multimeric RAFT-RGD decreased the lateral mobility of  receptors on the surface ofαvβ3
HEK293( ) cells. This suggested that the presence of four cRGD motifs onto the RAFT scaffold allowed the clustering of integrin .β3 αvβ3
This result is important because it suggested at least two cRGD motifs presented by a single RAFT molecule can bind two integrins. This
was an open challenge for the RAFT scaffold, which is no more than 10  large. Indeed, the three-dimensional structure of purified Å αvβ3
integrin showed that the diameter of this integrin is close to 100  , but that the RGD binding site is on the periphery of the molecule.Å [39]
The 2 RGD motifs presented by a single RAFT could thus bridge 2 integrins positioned back to back. This was confirmed by EM results,
which indicated that the tetrameric, but not the monomeric cRGD, could form clusters of 2 integrins. Formation of these  clusters wasαvβ3
then immediately followed by an active internalization of the tetrameric RAFT-RGD-Cy5 via, and concomitantly with integrin .αvβ3
Indeed, the natural endocytosis of this integrin almost doubled in less than 10 min in the presence of RAFT-RGD and its internalization
was mainly involving clathrin-mediated endocytosis. Accordingly, this process was abolished in the presence of amantadine, a specific
inhibitor of the clathrin-mediated endocytosis. Macropinocytosis and caveolae-mediated endocytosis may not be implicated since their
inhibitors like amiloride or nystatin had no effect on RAFT-RGD internalization. Interestingly, the monomeric cRGD peptide interacted in
a completely different manner. Its internalization did not rely on clathrin- or caveolae-mediated endocytosis and was most probably
independent of  because of the internalization of the integrin which was not affected. These results are in agreement with a previousαvβ3
report and indicated that cRGD can probably cross cell membranes via a fluid-phase pathway . The corresponding efficiency of[24]
internalization is however much less efficient than that of the RAFT-RGD, which explains the lower intensity of staining of the inside of
cells labeled with cRGD-Cy5 and as demonstrated by the indexes in .Figure 4
Viruses such as foot-and-mouth disease virus  or adenovirus present several RGD motifs allowing their interaction with the [43] αvβ3
integrin. This interaction is a prerequisite to their internalization , , which also occurs via clathrin-coated vesicles . RAFT-RGD[32 44] [45]
may thus mimic some properties of these viruses.
In summary, the tetrameric RAFT-RGD binds 10 times more strongly to its  receptor than cRGD. RAFT-RGD is actively andαvβ3
efficiently internalized with integrin  via clathrin-coated pits as previously described for the  integrin . This contrasts with theαvβ3 αvβ3 [46]
trafficking route followed by the  integrin, which was shown to use preferentially a caveolae-dependent pathway . Efficientβ1 [47]
internalization is of course an important issue for drug delivery and we proved that this RAFT-RGD molecule is indeed capable of
inducing a specific and efficient targeted intracellular delivery of a toxic peptide able to destabilize mitochondria .[13]
From this study, multimeric presentation of cRGD motifs appears to be a prerequisite for the development of efficient integrin
targeting and cell internalizing vectors for drug delivery to tumors.
Materials and Methods
Material
Integrin  was purchased from Chemicon International (CC1021, St Quentin en Yvelines, France). Monoclonal antibodyαvβ3
anti-human integrin  LM609 conjugated to R-PhycoErythrin (RPE-LM609) and anti-human CD61 were purchased from Chemiconαvβ3
and Beckman Coulter respectively (IM0540, Villepinte, France). Cycloheximide was from Sigma Aldrich (Lyon, France). NHS-SS-biotin
was from Pierce (21441, Brebi res, France).è
RGD-Peptides Synthesis and Fluorescent Labeling
Compounds were synthetized according to previously reported procedures  and chemical structures are presented in .[34] Fig. 1a
Briefly, RAFT is a cyclic decapeptide (c -Lys(Boc)-Lys(Alloc)-Lys(Boc)-Pro-Gly-Lys(Boc)-Lys(Alloc)-Lys(Boc)-Pro-Gly- ) having two[ ]
orthogonally addressable domains pointing on either side of the cyclopeptide backbone. On the upper face, four copies of the c -RGDfK-[ ]
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peptide were grafted via an oxime bond (R1-O-N  C-R2) for recognition of the integrin . On the other side of the RAFT, either Cy5= αvβ3
mono NHS (N-hydroxysuccinimide) ester (Amersham Biosciences, Uppsala, Sweden) or FITC (Sigma-Aldrich, St Quentin Fallavier,
France) was added on the lysine chain (c -KKKPGKAKPG- ) . As a negative control probe, Cy5-labeled RAFT(c -R ADfK- )[ ] [17] [ β ] 4
(RAFT-RAD) was also synthesized in a similar way.
FCS analysis
FCS study was performed on the ConfoCor 2 system (Carl Zeiss, Jena, Germany) using a 40  water immersion C-Apochromat×
objective lens (numerical aperture (N.A.)  1.2). The measurements were carried out at room temperature in 8-well Lab-Tek I chambered=
coverglass (Nalge Nunc Int., Illkirch, France). The 633 nm He Ne laser beam was focused into 50 l solutions at 150 m over the cover– μ μ
glass. The fluorescence emission was collected through a pinhole and a 650 nm-long pass filter. Photon counts were detected by an
Avalanche PhotoDiode (APD) at 20 MHz for 30 sec. For each sample, FCS measurements were repeated 15 times. The data evaluation
was performed using the Zeiss FCS Fit software. Most of the intensity autocorrelation curves were fitted using a free diffusion model with
two components: the peptide coupled to the fluorochrome alone and the fluorescent peptide integrin complex. Preliminary studies enabled–
us to determine the diffusion time value of the first component and structural parameter. Moreover, a calibration step with 4 nM Cy5
allowed the evaluation of the size of the confocal volume (  1 fl). Interaction assays were performed at RT in HBSS containing Mg  and≈ 2+
Ca . One to 40 nM of soluble integrin  (CC1021, Chemicon Int., France) were mixed with 0.6 nM of RAFT-RGD-Cy5 and2+ αvβ3
RAFT-RAD-Cy5 or 2.4 nM of cRGD-Cy5. FCS measurements were performed 2 min after mixing. Theoretical calculation was made
using the Origin software. The goodness-of-fit (Xhi ) was the mean end point for the quality of the fit (in our condition, 5E <Xhi <1E2 4− 2 6−
for a good fit). Furthermore, the residual curves had no wavy shape (see example in ).supplementary data
Cell Lines and Culture Conditions
HEK293( ), stable transfectants of human  from the human embryonic kidney cell line (kindly provided by J-F. Gourvest, Aventis,β3 β3
France), were cultured as described in Jin et al. . The cell line was cultured at 37 C in a humidified 95  air/5  CO  atmosphere.[15] ° % % 2
Confocal Laser Scanning Microscopy and FRAP Experiments
HEK293( ) cells were grown for 24 h on 18 mm round cover glasses placed in the wells of a 12-well plate (seeding density of 7  10β3 × 4
cells per well). Immediately before running the experiment, cells were incubated for 8 min at RT (22 C) in a mixture of°
R-PhycoErythrinconjugated LM609 monoclonal antibody (RPE-LM609, Chemicon Int.) and 0.5 M FITC-labeled RGD peptides. Theμ
incubation with monovalent cRGD was performed at either 0.5 M or 2 M. The antibody and peptide solutions were extemporaneouslyμ μ
prepared in HBS buffer enriched with 1 mM MgCl . For microscopic observations, coverslips were rinsed once in HBS buffer and2
disposed on a custom-made incubation chamber containing 200 L of the FITC-labeled RGD peptide solutions (0.5 M or 2 M withμ μ μ
cRGD). The confocal imaging and FRAP measurements were carried out on an inverted confocal microscope (LSM510, Carl Zeiss, Jena,
Germany) using a 40x water immersion objective of 1.2 N.A. A pinhole adjustment resulted in a 2.5 m optical slice used for theμ
visualization of a 25 m circular region of the cell apex membrane at scan zoom 4. For FRAP experiments, a 3 m circular ROI wasμ μ
uniformly bleached for 2 sec with 100  intensity of the 543 nm line (fluorescence bleaching ratio > 90 ). The fluorescence recovery was% %
then sampled on the whole region for 170 sec every 5 sec with 0.1  laser intensity set with AOTF. Thanks to the extremely small%
excitation power and short acquisition times, no photobleaching was induced during sampling as observed on control cells or on the
membrane out of the bleached ROI. Neither lateral nor axial displacement of ROI was observed during FRAP measurements and no
recovery of fluorescence was observed on the entirely bleached control cells.
Data analysis was performed in assumption that the recovery of fluorescence in the ROI was solely due to the two-dimensional
cytoplasmic diffusion of fluorescent species. The diffusion time  was determined by fitting the normalized fluorescence recovery curves dτ
 to the recovery kinetics equation: , F(t) [48 49]
where t is time, and   are initial and final mean fluorescence intensities after photobleaching respectively, I  and I  are modifiedF  0 F ∞ 0 1
Bessel functions. The diffusion time values obtained for each peptide conditions are the mean of 20 individual cells.
Electron microscopy
Soluble human integrin  (Chemicon, CC1021) was diluted to 0.095 mg/ml (  3.65 fmol) in PBS containing MgCl  and CaCl  at 1αvβ3 # ≈ 2 2
mM and mixed with RAFT-RGD 0.45 mg/ml (  1 nmol), cRGD 0.1 mg/ml (  1 nmol) or RAFT-RAD 0.45 mg/ml (  1 nmol) for 2 min≈ ≈ ≈
before addition on top of a carbon-coated electron microscope grid. Thirty sec later, the excess of liquid was removed by blotting with a
filter paper. Four ml of a 2  Uranyl Acetate solution were placed on the grid and incubated for 30 sec  1 min at room temperature. The% –
staining solution was subsequently removed by filter paper adsorption, and the grid was dried on a paper filter for 2 min and then
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examined using an electron microscope. Micrographs were taken under low-dose conditions with a Jeol 1200-EX II microscope at 100 kV
or a FEI CM12 microscope at 120 kV and a respectively calibrated magnification of 40000 and 45000 times. Selected negatives films were
digitalized on a Zeiss scanner (Photoscan TD) with a pixel size of 14 mm, corresponding to 3.5  or 3.1  at the sample scale.Å Å
Confocal Microscopy of Peptide Internalization
HEK293( ) cells were grown as described in 4-wells Lab-Tek I chambered coverglass. Cells were starved 30 min and incubated withβ3
DMEM w/o red phenol alone or containing amantadine 1 mM, nystatin 1 M or amiloride 1 mM for another 30 min at 37 C, 5  CO .μ ° % 2
Then, 1 mM RAFT-RGD-Cy5 or 1 mM cRGD-Cy5 were added to the culture medium, together with 5 M of Hoechst, for 10 min.μ
Confocal microscopy was performed on the Axiovert 200 LSM510 LNO Meta microscope (Carl Zeiss, Jena, Germany) using a 40x oil
immersion objective of 1.2 N.A., after addition of fresh medium. The 633 nm laser intensity was set up on request at 10 or 30  of its%
maximum intensity depending on the peptide. The following inhibitors were used in order to block caveolae, clathrin-coated pits or
macropinocytosis: nystatin 1 M, amantadine 1 mM, or amiloride 1 mM (Sigma Aldrich).μ
Peptides internalization was quantified from confocal microscopy analysis. The mean Cy5 intensity was related to the cell area (in
pixel); the related index is reported on the pictures.
Integrin internalization assay
Surface biotin labeling and internalization
HEK293( ) cells were cultured at ~85  confluence in 90 mm dishes and starved at 37 C for 30 min in DMEM containing 15 M ofβ3 % ° μ
cycloheximide (Sigma Aldrich, St Quentin Fallavier, France). Membrane labeling was adapted from Roberts et al. . Depending of the[50]
condition, cells were kept at 4 C or placed 10 min at 37 C in DMEM alone (control) or containing RAFT-RGD or cRGD from 0.1 to 4 ° ° μ
M, in order to allow receptor internalization.
In order to measure endocytosis inhibition, amantadine 1 mM, nystatin 1 M or amiloride 1mM were added to the medium 30 minμ
before biotin labeling. Those inhibitors were kept in the medium during biotin labeling and peptides internalization.
ELISA
Integrin internalization was quantified using Enzyme Linked ImmunoSorbent Assay in 96-wells plate, through gentle agitation. The
previous day, 0.2 g of mAb anti-human CD61 (IM0540, Beckman Coulter, France) were used to coat wells (n 3 wells/condition) byμ =
incubating overnight at 4 C under gentle agitation. Antibodies were removed and unspecific sites were blocked with 300 l of PBS/BSA 3° μ
/0.05  tween for 1 h et RT. Wells were washed 3 times with 300 l PBS/0.05  tween for 5 min before addition of 50 g of protein% % μ % μ
lysates adjusted to 200 l with lysis buffer, for 1 h at RT. Wells were washed again 5 times with 300 l PBS/0.05  tween for 5 min. Then,μ μ %
200 l of streptavidin-POD/PBS/0.05  tween (1:10000) (11 089 153 001, Roche Diagnostic, Meylan, France) were added onμ %
anti-CD61/biotinylated integrin complex for 1 h at RT. Samples were washed 3 times with 300 l PBS/0.05  tween and 2 times with 300 μ %
l PBS for 5 min. At last, integrin internalization was revealed using ABTS kit (00-2011, Zymed, Cergy Pontoise, France) and quantifiedμ
as described by the manufacturer.
Results were expressed as mean of OD /  S.E.M. and each experiment was performed in quadruplet at least.+ −
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(a) Chemical structures of RGD peptides. The monovalent -RGDfK-  (cRGD) was compared with the tetrameric RAFT(c -RGDfK- )cyclo[ ] [ ]4
(RAFT-RGD). cRGD was modified on the lysine side chain to obtain the fluorochrome-conjugated cRGD-FITC or cRGD-Cy5. For
RAFT-RGD, fluorochromes were conjugated to the lower face of the RAFT scaffold (central alanine residues replaced by lysine). RAFT(c -R[
ADfK- ) (RAFT-RAD) was used as negative control. (b) FCS analysis of the interaction of Cy5-labeled peptides with soluble integrins atβ ]4
633 nm. K  was determined at the equilibrium. The diffusion time and the diffusion coefficients  of the peptides alone or in a complexD τ  D D
with the integrin are indicated. Data were best-fitted by a two-components model and are represented as mean  standard deviation (SD).±
Representative plots are available in the  file.supplementary data
Figure 2
RAFT-RGD-FITC reduces  integrin lateral mobilityαvβ3
R-PhycoErythrin-conjugated LM609 monoclonal antibody was used for direct observation of  integrin diffusion on the apical membraneαvβ3
of the cell. Adherent HEK293( ) cells were incubated with 0.5 M FITC-labeled RAFT-RGD or RAFT-RAD or 2 M cRGD-FITC or inβ3 μ μ
absence of peptides. The antibody LM609-RPE was also present during the 8 min of incubation with the peptides in order to follow integrin
lateral diffusion. After washing, the cells were observed on an inverted confocal microscope. Recovery of the integrin signal into the bleached
area is significantly slowed down in the condition where cells were incubated in the presence of the multimeric RGD-presenting ligand,
RAFT-RGD-FITC, as compared to non-treated cells, or to RAFT-RAD-FITC or cRGD-FITC treated cells.
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Representative examples of negatively stained electron micrographs of the soluble  integrin alone or mixed with RGD-peptides. The αvβ3 αvβ3
integrins remain in monomeric state except when using RAFT-RGD; in this condition, integrins can be found as dimers on the grid. As
expected, RGD-peptides (<6 kDa) were not distinguishable. Upper panels: Original images. Lower panels: Photoshop enhanced visualization
of the complexes.
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Figure 4
Confocal imaging on HEK293( ) living cellsβ3
Cells were starved for 30 min and incubated with 1 mM RAFT-RGD-Cy5 (a  d) or 1 mM cRGD-Cy5 (e  h) for 10 min at room temperature– –
in DMEM medium alone (a, e) or containing amantadine 1 mM (b, f), nystatin 1 M (c, g) or amiloride (d, h). Cells were then rinsed andμ
observed at 633 nm. Peptide internalization was evaluated according to the Cy-5 intensity in the cells and is indicated for each photo. Scale
bar: 10 m.μ
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Table 1
Integrin  internalization assay.αvβ3
Peptide Concentrations ( M)μ % Internalized integrins Variation ( ) % a
none 11.99 1.13± -
0.1 17.18 1.08± + 43  % *
0.5 20.05  2.08± + 67  % **
RAFT-RGD 1 21.41 1.85± + 79  % ***
1  Amantadine+ 12.03 1.58± + 0  %** b
1  Nystatin+ 19.67 1.42± + 64%NS b
1  Amiloride+ 19.91 2.80± + 66%NS b
0.1 11.67 1.31± −3%NS
cRGD 0.5 10.76 1.08± −10%NS
1 11.77 1.00± −2%NS









 < 0.001  controlP vs.
 
a Variations of internalization were compared to the control condition (absence of peptide). Results were expressed as mean /  S.E.M. and each experiment was performed in quadruplet at least.+ −
 
b P values calculated  RAFT-RGD 1 M.vs. μ
